GSK 366
GSK 366 is a potent kynurenine-3-monooxygenase (KMO) inhibitor with IC50s of 2.3 nM and 0.7 nM for human KMO and P. fluorescens-KMO (Pf-KMO), respectively[1].
Product Specifications
CAS Number
1953157-39-5
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/gsk-366.html
Purity
99.80
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(O)CCC1=NOC2=C1C=C(Cl)C(O[C@@H](C3=NN=C(C)C=C3)C)=C2
Molecular Formula
C17H16ClN3O4
Molecular Weight
361.78
References & Citations
[1]Hutchinson JP, et al. Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase. Nat Commun. 2017 Jun 12;8:15827.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Slc17a8 Mouse Monoclonal Antibody [Clone ID: N34/34]](https://cdn.genprice.uk/products/937/68dd1898061270361e8fb39c/imageurl/75-073.webp)
HA723577B 100 µL
Human CD62L Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details 
GM-208-15 1 mL
Colloidal Gold Conjugated Monoclonal Antibody to Human IgG4 GB7B, 15nm
Sign In for Pricing
View Details 